Skip to main content
Home

Breadcrumb

  1. Home
  2. Healthcare and Life Science

Healthcare and Life Science

Preventing patient hospitalisation
30 July 2025

Preventing patient hospitalisation through better stratification and timely intervention

In the realm of healthcare, patient hospitalisation can often be avoided through timely intervention and appropriate medication management. One powerful strategy to achieve this is patient stratification—classifying patients into different groups based on their vulnerability to hos...

Dr. Erin Duffy, Chief of Research and Development, CARB-X	Dr. Jennifer Schneider, Chief Executive Officer, Centauri Therapeutics
29 July 2025

Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials

CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidateCentauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026CARB-X’s addition...

Dr Catherine Beech, CEO, Exonate	Imaging from Phase IIa study demonstrates significant reduction in vascular leakage, a critical marker for NDPR
29 July 2025

Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease

EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedemaPhase IIb trial to investigate efficacy in NPDR patients to commence in Q1 2026Cambridge, UK, 29 July 2025: E...

Dr Adam Gilbert, SAB Member, PhoreMost
28 July 2025

PhoreMost appoints Dr Adam Gilbert to Scientific Advisory Board

Expert in targeted protein degradation and drug discovery will support development of the Company’s portfolio of novel small molecule degraders ...

RAEN Eyewear at Taank Optometrists, Cambridge
21 July 2025

RAEN & Shine

Authenticity is key for the latest brand to join Taank's stable. RAEN’s designers live and breathe ocean adventures and have a deep respect for nature. They share this reverence through their beautiful 'modern classic' frames that emit the warmth and energy of SoCal while remaining root...

Female patient using Rodenstock eye scanner during eye exam
21 July 2025

The world’s most precise eye test: Rodenstock DNEye® Scanner

Taank is the proud new owner of Rodenstock’s high-precision DNEye® Scanner, which will be used during every eye exam. This revolutionary scanner is the first of its kind to map each eye with absolute precision. Find out more about what it does and why we love it. ...

Cancer survivor Stephanie Hemming, shortly after her robotic surgery
28 July 2025

A cancer survivor who underwent complex ‘very major surgery’ has praised the robotic surgery that removed all traces of the disease from her body

Cancer survivor Stephanie Hemming, from Cambridge, underwent complex, major surgery in January - with a surgeon performing robotic surgery on her following her diagnosis of pancreatic cancer. Here, she talks about her diagnosis, her praise for both the surgeon who performed the surgery ...

L-R Consultant Colorectal Surgeon Michael Powar with Siong-Seng Liau, a Consultant Hepatobiliary and Pancreatic Surgeon and Chair of the Robotic Steering Group at Addenbrooke’s with patient Stephanie Hemming
28 July 2025

Top robotic surgeons at Addenbrooke’s say robots unlikely to ever fully replace them in theatre – but say they could ‘co-pilot’  

Researchers from Johns Hopkins University in the US have reported that a robot had performed realistic surgery on its own with 100% accuracy.  Having trained on videos of surgeries, the robot was able to remove a gallbladder from a life-like patient, performing a total of 17 tasks...

Cambridge and AstraZeneca - a decade of partnership and impact
23 July 2025

Milner Therapeutics Institute featured in AstraZeneca-University of Cambridge partnership impact report

The Milner Therapeutics Institute is delighted to be featured in a new report celebrating a decade of partnership and impact between AstraZeneca and the University of Cambridge ...

PhoreMost GlueSeeker
22 July 2025

PhoreMost demonstrates new approach to rationalise molecular glue drug discovery

 Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space ...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 75
  • Page 76
  • Current page 77
  • Page 78
  • Page 79
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS